Endobronchial Injection of Botulinum Toxin for the Reduction of Bronchial Hyperreactivity Induced by Methacholine Inhalation in Dogs
- 1 October 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 19 (4) , 277-283
Abstract
Background: Airway smooth muscle contraction causes bronchial constriction and is the main cause of bronchospasm in response to stimulants in asthma patients. In this pilot study, we tested the possibility of using a commercially available neurotoxin—botulinum toxin A (BTX-A)—to reduce bronchial hyperreactivity in dogs. Methods: Two bronchoscopic sessions were conducted in 6 healthy mongrel dogs. In the first session, BTX-A (concentration 10 U/mL) was injected in small aliquots submucosally in 1 caudal lobe and its subsegments, leaving the other side as control. During the second bronchoscopy conducted 2 weeks later, the airway calibers of the treated and untreated sides were measured in each animal before and after instillation of methacholine in the airways to induce bronchial hyperreactivity (concentration 25 mg/mL). Results: The mean pretreatment diameter was 3.356 (±1.294) mm and 2.765 (±0.603) mm in the treated and untreated airways, respectively. After provocation with methacholine, the diameter of the treated airways was 1.985 (±0.888) mm versus 0.873 (±0.833) mm in the untreated airways (P=0.000). Local injection of BTX-A in the airway resulted in reduction of bronchial hyperreactivity by 58.6% (P=0.001). There were no complications resulting from the submucosal injection of BTX-A in the airways. Conclusions: Endobronchial injection of BTX-A reduces bronchial hyperreactivity in the airways of healthy dogs.Keywords
This publication has 11 references indexed in Scilit:
- Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Experience With 100 Cases Treated With Botulinum-A Toxin Injections in the Detrusor Muscle for Idiopathic Overactive Bladder Syndrome Refractory to AnticholinergicsJournal of Urology, 2006
- Inflammatory events in severe acute asthmaAllergy, 2004
- Contribution of the Distal Lung to the Pathologic and Physiologic Changes in AsthmaChest, 2003
- CONSEQUENCES OF LONG-TERM INFLAMMATIONClinics in Chest Medicine, 2000
- Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasiaMuscle & Nerve, 1998
- Botulinum-A Toxin as a Treatment of Detruosor-Sphincter Dyssynergia: A Prospective Study in 24 Spinal Cord Injury PatientsJournal of Urology, 1996
- Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressureJournal of Applied Physiology, 1992
- Human Respiratory Tract Secretions. 2. Effect of Cholinergic and Adrenergic Agents on in vitro Release of Protein and Mucous GlycoproteinChest, 1975
- Cytology of Respiratory Epithelium as a Predictor of Respiratory Complications after OperationChest, 1975